Finance

Lists
Why is CHM down 20.00%?
Dive Deeper
CHM:ASX
Chimeric Therapeutics Ltd
A$0.0040
-20.00%
(-0.00100) 1D
Sep 30, 10:09:25 AM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CHM...
Open
A$0.00
High
A$0.00
Low
A$0.00
Mkt. cap
236.26K
Avg. vol.
2.22M
Volume
8.30M
52-wk high
A$0.40
52-wk low
A$0.00
EPS
-A$0.61
Shares outstanding
118.13M
Open
A$0.00
High
A$0.00
Low
A$0.00
Mkt. cap
236.26K
Avg. vol.
2.22M
Volume
8.30M
52-wk high
A$0.40
52-wk low
A$0.00
EPS
-A$0.61
Shares outstanding
118.13M
News stories
From web sources and news partners
About Chimeric Therapeutics Ltd
CEO-
Employees-
Founded2020
Headquarters-
SectorBiotechnology
Websitechimerictherapeutics.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.31M
1.31M
-1.40M
-1.40M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
399.44K
399.44K
1.31M
1.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.35M
1.35M
953.59K
953.59K
Operating expense
1.94M
1.94M
2.23M
2.23M
Total operating expenses
1.94M
1.94M
2.23M
2.23M
Operating income
-634.86K
-634.86K
-3.64M
-3.64M
Other non operating income
-
-
-8.94K
-8.94K
EBT including unusual items
-5.59M
-5.59M
-3.81M
-3.81M
EBT excluding unusual items
-709.86K
-709.86K
-3.55M
-3.55M
Income tax expense
21.60K
21.60K
-10.53K
-10.53K
Effective tax rate
-0.39%
-0.39%
0.28%
0.28%
Other operating expenses
-
-
-
-
Net income
-5.61M
-5.61M
-3.80M
-3.80M
Net profit margin
-428.19%
-428.19%
270.30%
270.30%
Earnings per share
-
-
-
-
Interest and investment income
13.78K
13.78K
5.84K
5.84K
Interest expense
-88.79K
-88.79K
-55.19K
-55.19K
Net interest expenses
-75.01K
-75.01K
-49.35K
-49.35K
Depreciation and amortization charges
-
-
-
-
EBITDA
-391.47K
-391.47K
-3.62M
-3.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps